- Report
- February 2024
- 70 Pages
Egypt
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
United Kingdom
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
France
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Saudi Arabia
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Mexico
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Spain
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Vietnam
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Iran
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Russia
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Australia
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
China
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Japan
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
Japan
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4519EUR$4,750USD£3,870GBP
- Report
- August 2023
- 70 Pages
Spain
From €4519EUR$4,750USD£3,870GBP
- Report
- August 2023
- 70 Pages
South Korea
From €4519EUR$4,750USD£3,870GBP
- Report
- October 2022
- 176 Pages
Global
From €4519EUR$4,750USD£3,870GBP
Humulin is a brand of insulin used to treat endocrine and metabolic disorders. It is a recombinant human insulin, produced by genetically engineered bacteria, and is used to treat diabetes mellitus. It is available in several forms, including short-acting, intermediate-acting, and long-acting. Humulin is used to control blood sugar levels in people with type 1 and type 2 diabetes. It is also used to treat other endocrine and metabolic disorders, such as hyperglycemia, hypoglycemia, and polycystic ovary syndrome.
Humulin is a widely used insulin, and is available in many countries around the world. It is available in both generic and branded forms, and is available in both injectable and oral forms. It is also available in combination with other medications, such as metformin and glipizide.
The Humulin market is highly competitive, with many companies offering their own versions of the drug. Some of the major companies in the market include Eli Lilly, Novo Nordisk, Sanofi, Merck, and Pfizer. Show Less Read more